Serum neopterin levels in patients with replicative and nonreplicative HBV carriers

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Kaleli, Ilknur ^a   Demir, Melek ^a   Cevahir, Nural ^a   Yilmaz, Mustafa ^a   Demir, Suleyman ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; NEOPTERIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BINDING COMPETITION; BLOOD LEVEL; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MICROBIOLOGICAL EXAMINATION; STATISTICAL SIGNIFICANCE; VIRUS CARRIER; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CARRIER STATE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; NEOPTERIN; VIRUS REPLICATION;

EID: 33751077476     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-157     Document Type: Article

References (22)

1. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, Frösner G, Will H, Pape GR: Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virology 1995, 69:3358-3368.
2. Fuchs D, Weiss G, Reibnegger G, Wachter H: The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases, Crit Rev Clin Lab Sci 1992, 29:307-341.
3. Fuchs D, Weiss G, Wachter H: Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Immunol 1993, 101:1-6.
4. Azumagawa K, Suziki S, Tanabe T, Wakamiya E, Kawamura N, Tamai H: Neopterin, biopterin and nitric oxide concentrations in the cerebrospinal fluid of children with central nervous system infections. Brain & Development 2003, 25:200-202.
5. Adamik B, Kübler-Kielb J, Golebiowska B, Gamian A, Kübler A: Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000, 26:1259-1267.
6. Tanaka J, Koshimura K, Tsumori M, Murakami Y, Kato Y: Monitoring of urine nitric oxide (NO) related substrates and immunological competence in hematological malignancy. Acta Biochim Polonica 2002, 49:227-232.
7. Kallio R, Surcel HM, Bloigu A, Syrjala H: Admission neopterin and interleukin 12 concentrations in identifying infections in adult cancer patients. Cytokine 2001, 13:371-374.
8. Idilman R, Arat M, Soydan E, Törüner M, Soykan I, Akbulut H, Arslan Ö, Özcan M, Türkyilmaz AR, Bozdayi M, Karayalçin S, Van Thiel DH, Özden A, Beksaç M, Akan H: Lamuvidine prophylaxis for prevention chemotherapy-induced Hepatitis B Virus reactivation in Hepatitis B carriers with malignancies. J Viral Hepat 2004, 11:141-147.
9. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T: Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003, 98:144-150.
10. Müller MM, Curtius HC, Herold M, Huber CH: Neopterin in clinical practice. Clinica Chimica Acta 1991, 201:1-16.
11. Fahey JL, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey JL, Seigel J, Landay AL, Kilarui R, Schmitz JL, White C, Wara DW, Akridge R, Cutili J, Douglas SD, Reuben J, Shearer WT, Nokta M, Polland R, Schooley R, Asthana D, Mizrachi Y, Waxdal M: Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation. Clin Diagn Lab Immunol 2000, 7:540-548.
12. Fuchs D, Shearer MG, Boswell RN, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H: Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clin Exp Immunol 1990, 80:44-48.
13. Aziz N, Nishanian P, Fahey JL: Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol 1998, 5:755-761.
14. Shi M, Taylor JM, Fahey JL, Hoover DR, Munoz A, Kingsley LA: Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression. J Clin Immunol 1997, 17:43-52.
15. Niesters HGM, Krajden M, Cork L, Medina M, Hill M, Fries E, Osterhaus ADME: A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol 2000, 38:2150-2155.
16. Sack U, Burkhardt U, Borte M, Schadlich H, Berg K, Emmrich F: Age-dependent levels of select immunological mediators in sera of healthy children. ClinDiagn Lab Immunol 1998, 5:28-32.
17. Daito K, Suou T, Kawasaki H: Clinical significance of serum and urinary neopterin levels in patients with various liver diseases. Am J Gastroenterol 1992, 87:471-476.
18. Kiliç D, Boyunaǧa H, Kaygusuz S, Akgül EÖ, Rashed MA, Kenar L, Erbil K, Kutluay T: Neopterin levels in nonreplicative HBV carriers. Hepatology Research 2002, 24:18-22.
19. Fernandez E, Rodrigo L, Riestra S, Garcia S, Gutierrez F, Ocio G: Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol 2000, 30:181-186.
20. Kumashiro R, Ide T, Sasaki M, Murashima S, Suziki H, Hino T, Morita Y, Miyajima I, Ogata K, Tanaka E, Yoshida H, Tanikawa K, Sata M: Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C. Hepatology Research 2002, 22:20-26.
21. Grüngreiff K. Reinhold D, Ansorge S: Serum concentrations of sIL-2R, IL-6, TGF-β1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Cytokine 1999, 11:1076-1080.
22. Leonardi S, Avola E, Sciacca A, Di Gregorio F, Musumeci S: Neopterin as a marker of C hepatitis in thalassaemia major. J Pediatr Gastroenterol 1991, 12:315-318.